1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients. (1st January 2021) Authors: Van Wigcheren, Glenn F.; De Haas, Nienke; Mulder, Tom A.; Horrevorts, Sophie K.; Bloemendal, Martine; Hins-Debree, Simone; Mao, Yumeng; Kiessling, Rolf; van Herpen, Carla M.L.; Flórez-Grau, Georgina; Hato, Stanleyson V.; De Vries, I. Jolanda M. Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dendritic cell regulation of NK‐cell responses involves lymphotoxin‐α, IL‐12, and TGF‐β. Issue 6 (17th April 2015) Authors: Sarhan, Dhifaf; Palma, Marzia; Mao, Yumeng; Adamson, Lars; Kiessling, Rolf; Mellstedt, Håkan; Österborg, Anders; Lundqvist, Andreas Journal: European journal of immunology Issue: Volume 45:Issue 6(2015:Jun.) Page Start: 1783 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity. (6th November 2014) Authors: Mao, Yumeng; Sarhan, Dhifaf; Poschke, Isabel; Lundqvist, Andreas; Kiessling, Rolf Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control. (4th November 2015) Authors: Lundqvist, Andreas; Mao, Yumeng; Zhang, Xiaonan; Wennerberg, Erik; Van Hoef, Vincent; Larsson, Ola; Linder, Stig; Kiessling, Rolf Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control. Issue 2 (December 2015) Authors: Lundqvist, Andreas; Mao, Yumeng; Zhang, Xiaonan; Wennerberg, Erik; Van Hoef, Vincent; Larsson, Ola; Linder, Stig; Kiessling, Rolf Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. LRTCLS: low-rank tensor completion with Laplacian smoothing regularization for unveiling the post-transcriptional machinery of N6-methylation (m6A)-mediated diseases. Issue 5 (21st August 2022) Authors: Ma, Jiani; Liu, Hui; Mao, Yumeng; Zhang, Lin Journal: Briefings in bioinformatics Issue: Volume 23:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phosphodiesterase 4A confers resistance to PGE2‐mediated suppression in CD25+/CD54+ NK cells. (22nd January 2021) Authors: Chen, Ziqing; Yang, Ying; Neo, Shi Y; Shi, Hao; Chen, Yi; Wagner, Arnika K; Larsson, Karin; Tong, Le; Jakobsson, Per‐Johan; Alici, Evren; Wu, Jing; Cao, Yihai; Wang, Kai; Liu, Lisa L; Mao, Yumeng; Sarhan, Dhifaf; Lundqvist, Andreas Journal: EMBO reports Issue: Volume 22:Number 3(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗